Biden's Medicare drug price negotiations will leave pharma mostly unscathed: CBO

[cafead]

via The pharma industry should emerge mostly unscathed if President Joseph Biden's Build Back Better bill makes its way into law. While the legislation would open the door to limited Medicare negotiations and cap price hikes at the rate of inflation, the cost to the industry and its pace of innovation would be minimal, a government analysis found.

article source